AperionDx's AD Biomarker Kit is designed to revolutionize the early detection and prognostication of Alzheimer's Disease. This innovative blood-based panel quantifies key biomarkers, including Aβ40, Aβ42, p-tau181, and p-tau217, providing critical insights into cognitive decline years before symptoms appear. With our proprietary Protein-PCR technology, you can leverage existing qPCR instruments in your lab for accurate and efficient biomarker detection.
Key Features
- High Sensitivity: Achieves over 97.5% positive/negative percent agreement with competing methods.
- Multiplexed Detection: Detects multiple biomarkers in a single well, saving time and resources.
- Rapid Results: Delivers results in under 4 hours, enabling quick decision-making.
- Compatible with Existing Equipment: Utilizes standard qPCR instruments, eliminating the need for new hardware.
- Scalable: Available in 96- and 384-well plate formats to meet varying laboratory needs.
Benefits for Research and Development
The AD Biomarker Kit is an invaluable tool for research labs, biotech, and pharma R&D teams. It enables early risk detection and cognitive decline prognostication, facilitating the development of new therapeutics and diagnostic tools. The kit's high sensitivity and rapid turnaround time make it ideal for large-scale studies and clinical trials.
Benefits for Clinical Labs and Hospitals
Pending regulatory approval, the AD Biomarker Kit will be a game-changer for clinical labs and hospitals. It provides a non-invasive, blood-based method for early Alzheimer's detection, allowing for timely intervention and improved patient outcomes. The kit's compatibility with existing qPCR instruments ensures seamless integration into clinical workflows.
How It Works
The AD Biomarker Kit leverages AperionDx's proprietary Protein-PCR technology to detect and quantify key Alzheimer's biomarkers in blood samples. The process involves the following steps:
- Sample Collection: Collect a blood sample from the patient.
- Sample Preparation: Prepare the sample for analysis using the provided reagents.
- PCR Analysis: Run the sample on a standard qPCR instrument using the kit's assays.
- Data Interpretation: Analyze the results to quantify the levels of Aβ40, Aβ42, p-tau181, and p-tau217.
Why Choose AperionDx's AD Biomarker Kit?
- Proven Technology: Backed by years of research and development, our Protein-PCR technology delivers reliable results.
- Compatible: Works with existing qPCR instruments, reducing the need for additional investments.
- Scalable: Available in multiple plate formats to accommodate different laboratory needs.
- Expertise: Led by a team with extensive experience in biochemistry, diagnostics, and regulatory affairs.
Next Steps
To learn more about the AD Biomarker Kit and how it can benefit your research or clinical practice, contact our sales team. We are here to answer your questions and provide the information you need to make an informed decision.
Frequently Asked Questions
What biomarkers does the AD Biomarker Kit detect?
The AD Biomarker Kit quantifies Aβ40, Aβ42, p-tau181, and p-tau217, which are key indicators of Alzheimer's Disease.
How long does it take to get results with the AD Biomarker Kit?
The kit delivers results in under 4 hours, making it ideal for quick decision-making in research and clinical settings.
Can the AD Biomarker Kit be used with existing qPCR instruments?
Yes, the kit is designed to be compatible with standard qPCR instruments, eliminating the need for new hardware.
Is the AD Biomarker Kit suitable for large-scale studies?
Absolutely. The kit's high sensitivity, rapid turnaround time, and scalability make it perfect for large-scale studies and clinical trials.
What are the benefits of early Alzheimer's detection?
Early detection allows for timely intervention, improved patient outcomes, and the development of new therapeutics and diagnostic tools.
How does the AD Biomarker Kit compare to other diagnostic methods?
The AD Biomarker Kit achieves over 97.5% positive/negative percent agreement with competing methods, ensuring high analytical sensitivity and reliability.